Anti-inflammatory effect of FR140423, a novel selective cyclo-oxygenase-2 inhibitor, in rat adjuvant arthritis without gastrointestinal side effects

Journal of Pharmacy and Pharmacology

Volumn 52, Issue 5, 2000, Pages 553-560

  Ochi, Takehiro ^a   Goto, Toshio ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (DIFLUOROMETHYL) 1 (4 METHOXYPHENYL) 5 [4 (METHYLSULFINYL)PHENYL]PYRAZOLE; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; LEUKOTRIENE B4; PROSTAGLANDIN E2; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; FEMALE; NONHUMAN; PAW EDEMA; RAT;

EID: 0034126248     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357001774192     Document Type: Article

References (30)

1. Anderson, G. D., Hauser, S. D., McGarity, K. L., Bremer, M. E., Isakson, P. C., Gregory, S. A. (1996) Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 97: 2672-2679
2. Bartlett, R. R., Schleyerbach, R. (1985) Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity: I. disease modifying action on adjuvant arthritis of the rat. Int. J. Immunopharmacol. 7: 7-18
3. Cao, C., Matsumura, K., Yamagata, K., Watanabe, Y. (1996) Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1β: a possible site of prostaglandin synthesis responsible for fever. Brain Res. 733: 263-272
4. Chan, C.-C., Boyce, S., Brideau, C., Charleson, S., Cromlish, W., Ethier, D., Evans, J., Ford-Hutchinson, A. W., Forrest, M. J., Gauthier, J. Y., Gordon, R., Gresser, M., Guay, J., Kargman, S., Kennedy, B., Leblanc, Y., Leger, S., Mancini, J., O'Neill, G. P., Ouellet, M., Patrick, D., Percival, M. D., Perrier, H., Prasit, P., Rodger, I., Tagari, P., Therien, M., Vickers, P., Visco, D., Wang, Z., Webb, J., Wong, E., Xu, L.-J., Young, R. N., Zamboni, R., Riendeau, D. (1999) Rofecoxib [Vioxx, MK-966; 4-(4′-methylsufonylphenyl)-3-phenyl-2 (5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor: pharmacological and biochemical profiles. J. Pharmacol. Exp. Ther. 290: 551-560
5. Crofford, L. J., Wilder, R. L., Ristimäki, A. P., Sano, H., Remmers, E. F., Epps, H. R., Hla, T. (1994) Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. J. Clin. Invest. 93: 1095-1101
6. Futaki, N., Yoshikawa, K., Hamasaka, Y., Arai, I., Higuchi, S., Iizuka, H., Otomo, S. (1993) NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen. Pharmacol. 24: 105-110
7. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., Otomo, S. (1994) NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47: 55-59
8. Hla, T., Neilson, K. (1992) Human cyclooxygenase-2 cDNA. Proc. Natl Acad. Sci. USA 89: 7384-7388
9. Iigo, Y., Takashi, T., Tamatani, T., Miyasaka, M., Higashida, T., Yagita, H., Okumura, K., Tsukada, W. (1991) ICAM-1-dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats. J. Immunol. 147: 4167-4171
10. Ishizuki, S., Kanda, N., Kaneta, S., Fujihira, E. (1984) Progressive foot swelling in BUF rats: a new animal model for screening of anti-inflammatory and anti-rheumatic drugs. Arch. Int. Pharmacodyn. 271: 303-314
11. Klickstein, L. B., Shapleigh, C., Goetzl, E. J. (1980) Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J. Clin. Invest. 66: 1166-1170
12. Litchfield, J. T., Wilcoxon, F. (1949) A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96: 99-113
13. Meade, E. A., Smith, W. L., DeWitt, D. L. (1993) Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268: 6610-6614
14. Newbould, B. B. (1963) Chemotherapy of arthritis induced in rats by mycobacterial adjuvant. Br. J. Pharmacol. 21: 127-136
15. Ochi, T., Fujii, T., Motoyama, Y., Goto, T. (1999a) The profile of FR140423, a novel anti-inflammatory compound, in yeast-induced rat hyperalgesia. Jpn. J. Pharmacol. 81: 94-98
16. Ochi, T., Jobo-Magari, K., Yonezawa, A., Matsumori, K., Fujii, T. (1999b) Anti-inflammatory and analgesic effects of a novel pyrazole derivative, FR140423. Eur. J. Pharmacol. 365: 259-266
17. Opas, E. E., Dallob, A., Herold, E., Luell, S., Humes, J. L. (1987) Pharmacological modulation of eicosanoid levels and hyperalgesia in yeast-induced inflammation. Biochem. Pharmacol. 36: 547-551
18. Peacock, D. J., Banquerigo, M. L., Brahn, E. (1995) A novel angiogenesis inhibitor suppresses rat adjuvant arthritis. Cell Immunol. 160: 178-184
19. Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., Graneto, M. J., Lee, L. F., Malecha, J. W., Miyashiro, J. M., Rogers, R. S., Rogier, D. J., Yu, S. S., Anderson, G. D., Burton, E. G., Cogburn, J. N., Gregory, S. A., Koboldt, C. M., Perkins, W. E., Seibert, K., Veenhuizen, A. W., Zhang, Y. Y., Isakson, P. C. (1997) Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazole-1-yl] benzenesulfonamide(SC-58635, Celecoxib). J. Med. Chem. 40: 1347-1365
20. Powell, W. S. (1980) Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins 20: 947-957
21. Powell, W. S. (1982) Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica.In: Lands, W. E. M., Smith, W. L. (eds) Methods in Enzymology, Vol 86. Academic Press, New York, pp 467-477
22. Sano, H., Hla, T., Maier, J. A. M., Crofford, L. J., Case, J. P., Maciag, T., Wilder, R. L. (1992) In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J. Clin. Invest. 89: 97-108
23. Schleyerbach, R., Wedde, H. (1984) Alteration in the gastrointestinal functions during the development of adjuvant disease in rats. Agents Actions 15: 392-397
24. Szczepanski, A., Moatter, T., Carley, W. W., Gerritsen, M. E. (1994) Induction of cyclooxygenase 2 in human synovial microvessel endothelial cells by interleukin-1. Arthritis Rheum. 37: 495-503
25. Theisen-Popp, P., Pape, H., Müller-Peddinghaus, R. (1992) Interleukin-6 (IL-6) in adjuvant arthritis of rats and its pharmacological modulation. Int. J. Immunopharmacol. 14: 565-571
26. Tsuji, K., Konishi, N., Spears, G. W., Ogino, T., Nakamura, K., Tojo, T., Ochi, T., Shimojo, F., Senoh, H., Matsuo, M. (1997) Studies on anti-inflammatory agents: V. Synthesis and pharmacological properties of 3-(difluoromethyl)-1-(4-methoxyphenyl)-5-[4-(methylsulfinyl)phenyl]pyrazole and related compounds. Chem. Pharm. Bull. 45: 1475-1481
27. Vane, J. R. (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol. 231: 232-235
28. Walz, D. T., DiMartino, M. J., Kuch, J. H., Zuccarello, W. (1971) Adjuvant-induced arthritis in rats I. Temporal relationship of physiological, biochemical, and hematological parameters. Proc. Soc. Exp. Biol. Med. 136: 907-910
29. Xie, W., Robertson, D. L., Simmons, D. L. (1992) Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal antiinflammatory drugs. Drug Dev. Res. 25: 249-265
30. Zimmermann, M. (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110